Proactive Investors - Run By Investors For Investors

Lexaria Bioscience shareholders approve the appointment of four directors

Shareholders approved all matters at the annual general meeting, including the appointment of Davidson & Company LLP as auditor
lab extracts
Lexaria's DehydraTECH technology can be applied to foods, beverages, cannabis, oral suspensions, tablets and capsules

Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP) reported a successful annual general meeting Friday, noting all matters were approved, including the appointment of four directors. 

The firm said directors appointed included: Chris Bunka, John Docherty, Nicholas Baxter and Ted McKechnie. The firm noted Davidson & Company LLP has been appointed as auditor. 

READ: Lexaria Bioscience crafts new DehydraTECH innovation, files patents

The firm noted shareholders also approved executive compensation.

Lexaria has developed and out-licenses its delivery technology, which promotes healthier ingestion methods and lower overall dosing. Its DehydraTECH technology is essentially a delivery system that allows drugs and vitamins to get into the bloodstream quicker, while making them taste and smell better at the same time. The firm acquired its technology in 2014. 

Lexaria's technology provides boosts in intestinal absorption rates and more rapid bloodstream delivery for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs, nicotine and other molecules.

The firm has patents pending in more than 40 countries.

Shares of Lexaria Bioscience were at C$1.10 on Friday. 

Contact Katie Lewis at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full LXX profile View Profile

Lexaria Bioscience Corp Timeline

Related Articles

medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
cannabis extract
January 16 2019
The Kelowna, BC-based cannabis company specializes in the research, development, production, and testing of high-quality cannabis extracts and oils
cannabis extraction
April 09 2019
NextLeaf Solutions is developing intellectual property around converting the cannabis plant into infused products through a scalable, repeatable process
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use